E. Mickiewicz

5.3k total citations
15 papers, 639 citations indexed

About

E. Mickiewicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, E. Mickiewicz has authored 15 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in E. Mickiewicz's work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). E. Mickiewicz is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). E. Mickiewicz collaborates with scholars based in Argentina, France and Australia. E. Mickiewicz's co-authors include Neil K. Aaronson, Peter D. Eisenberg, Emilio Bajetta, Camilla Fowst, E. Di Salle, Giorgio Massimini, M. Tubiana-Hulin, Robin Murray, Anna Polli and Paula Pitt and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Journal of Obstetrics and Gynecology.

In The Last Decade

E. Mickiewicz

14 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Mickiewicz Argentina 9 372 213 197 166 99 15 639
C Andreoli Italy 11 225 0.6× 113 0.5× 230 1.2× 88 0.5× 48 0.5× 34 569
D. P. Ryan United States 13 241 0.6× 56 0.3× 83 0.4× 180 1.1× 108 1.1× 31 510
Beatrice Gatteschi Italy 15 430 1.2× 91 0.4× 121 0.6× 311 1.9× 402 4.1× 33 821
W. Mattsson Sweden 15 271 0.7× 78 0.4× 60 0.3× 75 0.5× 74 0.7× 29 474
Fulvio Brema Italy 12 388 1.0× 78 0.4× 136 0.7× 67 0.4× 36 0.4× 36 562
Mauro Porpiglia Italy 11 456 1.2× 564 2.6× 449 2.3× 124 0.7× 26 0.3× 27 813
M. Azab France 6 547 1.5× 390 1.8× 303 1.5× 228 1.4× 53 0.5× 7 845
Xi‐Bin Sun China 13 311 0.8× 25 0.1× 107 0.5× 136 0.8× 186 1.9× 33 685
E. E. Holdener Switzerland 10 187 0.5× 85 0.4× 117 0.6× 128 0.8× 48 0.5× 16 611
Carmen Lilla Germany 9 181 0.5× 54 0.3× 188 1.0× 68 0.4× 51 0.5× 13 493

Countries citing papers authored by E. Mickiewicz

Since Specialization
Citations

This map shows the geographic impact of E. Mickiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mickiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mickiewicz more than expected).

Fields of papers citing papers by E. Mickiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mickiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mickiewicz. The network helps show where E. Mickiewicz may publish in the future.

Co-authorship network of co-authors of E. Mickiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of E. Mickiewicz. A scholar is included among the top collaborators of E. Mickiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Mickiewicz. E. Mickiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Posner, Marshall R., Charles M. Norris, Lori J. Wirth, et al.. (2009). Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Annals of Oncology. 20(5). 921–927. 102 indexed citations
2.
Cazap, Eduardo, Antônio C. Buzaid, Horacio Astudillo‐de la Vega, et al.. (2007). Breast cancer care in Latin America and the Caribbean (LAC). Journal of Clinical Oncology. 25(18_suppl). 21140–21140. 3 indexed citations
3.
4.
Cinat, Gabriela, et al.. (2005). Concurrent chemotherapy and radiotherapy in locally advanced cervical carcinoma (LACC): Anályis of two different radiosensitizer schedules. Journal of Clinical Oncology. 23(16_suppl). 5113–5113. 1 indexed citations
5.
Mickiewicz, E., et al.. (2004). Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer. Oncology. 66(1). 18–23. 28 indexed citations
6.
Mickiewicz, E., et al.. (2003). Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer.. PubMed. 17(12 Suppl 14). 22–5. 8 indexed citations
7.
Vinholes, J., Fernando Palacios Salas, E. Mickiewicz, et al.. (2001). A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis. European Journal of Cancer. 37. S167–S167. 9 indexed citations
8.
Lønning, Per Eystein, Emilio Bajetta, Robin Murray, et al.. (2000). Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial. Journal of Clinical Oncology. 18(11). 2234–2244. 242 indexed citations
9.
Lhommé, C., Jan B. Vermorken, E. Mickiewicz, et al.. (2000). Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study. European Journal of Cancer. 36(2). 194–199. 41 indexed citations
10.
Richardet, Eduardo, E. Mickiewicz, Guillermo Lerzo, et al.. (1999). Uracil/tegafur plus oral calcium folinate in advanced breast cancer.. PubMed. 13(7 Suppl 3). 96–7. 6 indexed citations
11.
Bruno, Salvador, E. Mickiewicz, Luis Alberto Gaitán-Cepeda, et al.. (1995). Phase II Trial of Weekly IV Vinorelbine as a Single Agent in First-Line Advanced Breast Cancer Chemotherapy. American Journal of Clinical Oncology. 18(5). 392–396. 72 indexed citations
12.
Rodríguez, R, et al.. (1993). IMPACT OF DELAY TO TREATMENT UPON SURVIVAL IN 1067 PATIENTS WITH BREAST-CANCER. International Journal of Oncology. 2(2). 197–201. 9 indexed citations
13.
Boczkowski, K & E. Mickiewicz. (1987). [Cytogenetic studies in Klinefelter's syndrome].. PubMed. 42(9). 257–9.
14.
Mickiewicz, E., et al.. (1976). LEVAMISOLE IN ADVANCED HUMAN BREAST CANCER. The Lancet. 307(7953). 211–215. 114 indexed citations
15.
Boczkowski, K, et al.. (1972). Familial occurrence of male pseudohermaphrodites with ambiguous external genitals. American Journal of Obstetrics and Gynecology. 112(2). 192–198. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Andreoli Breakdown of academic impact, for papers by D. P. Ryan Breakdown of academic impact, for papers by Beatrice Gatteschi Breakdown of academic impact, for papers by W. Mattsson Breakdown of academic impact, for papers by Fulvio Brema Breakdown of academic impact, for papers by Mauro Porpiglia Breakdown of academic impact, for papers by M. Azab Breakdown of academic impact, for papers by Xi‐Bin Sun Breakdown of academic impact, for papers by E. E. Holdener Breakdown of academic impact, for papers by Carmen Lilla
Rankless by CCL
2026